Pharming Group N.V. (PHAR) Reports Q1 Loss of $0.01, provides guidance

Pharming Group N.V. (NASDAQ: PHAR) reported Q1 EPS of ($0.01). Revenue for the quarter came in at $55.6 thousand, versus $0 reported last year.

GUIDANCE:

Pharming Group N.V. sees FY2024 revenue of $280-290 million, versus the consensus of $282.9 million. Overall cash and marketable securities of US$203.5 million at the end of the quarter

For earnings history and earnings-related data on Pharming Group N.V. (PHAR) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
• Burry doubles down on Nebius short after stock surges 34% on earnings